Wed, October 3, 2018
Tue, October 2, 2018
Mon, October 1, 2018
Fri, September 28, 2018

Alethia Young Initiated (BIIB) at Buy and Held Target at $400 on, Oct 1st, 2018

Alethia Young of Cantor Fitzgerald, Initiated "Biogen Inc." (BIIB) at Buy and Held Target at $400 on, Oct 1st, 2018.

Alethia has made no other calls on BIIB in the last 4 months.



There are 7 other peers that have a rating on BIIB. Out of the 7 peers that are also analyzing BIIB, 2 agree with Alethia's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoff Meacham of "Barclays" Maintained at Hold with Increased Target to $320 on, Wednesday, July 25th, 2018
  • Brian Skorney of "Baird" Maintained at Hold with Increased Target to $348 on, Wednesday, July 25th, 2018


These are the ratings of the 5 analyists that currently disagree with Alethia


  • Thomas Shrader of "Stifel" Initiated at Strong Buy and Held Target at $394 on, Tuesday, August 7th, 2018
  • Carter Gould of "UBS" Maintained at Strong Buy with Increased Target to $395 on, Thursday, July 26th, 2018
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $392 on, Wednesday, July 25th, 2018
  • Sumant Kulkarni of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $396 on, Monday, July 23rd, 2018
  • Robyn Karnauskas of "Citigroup" Upgraded from Hold to Strong Buy and Held Target at $371 on, Friday, July 6th, 2018